BR0016523A - Atividade sonogênica de bactérias não patogênicas de ácido láctico - Google Patents

Atividade sonogênica de bactérias não patogênicas de ácido láctico

Info

Publication number
BR0016523A
BR0016523A BR0016523-9A BR0016523A BR0016523A BR 0016523 A BR0016523 A BR 0016523A BR 0016523 A BR0016523 A BR 0016523A BR 0016523 A BR0016523 A BR 0016523A
Authority
BR
Brazil
Prior art keywords
lactic acid
acid bacteria
pathogenic lactic
sonogenic
activity
Prior art date
Application number
BR0016523-9A
Other languages
English (en)
Inventor
James M Krueger
Michael J Pabst
Chantal Cayuela
Marie-Christine Degivry
Donna Hartley
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of BR0016523A publication Critical patent/BR0016523A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"ATIVIDADE SONOGêNICA DE BACTéRIAS NãO PATOGêNICAS DE áCIDO LáCTICO". Bactérias do ácido láctico não patogênicas têm paredes celulares as quais são suscetíveis à digestão por enzimas tipo muramidase, as quais produzem fragmentos referidos como muramilpeptídeos. A ingestão de muramilpeptídeos, ou diretamente, ou por digestão de bactérias do ácido láctico não patogênicas, estimula o sono e melhora a qualidade do sono. Em particular, aumenta a fase do sono de movimentos não rápidos dos olhos. Os produtos da digestão de muramilpeptídeos de bactérias do ácido láctico não patogênicas estimulam a produção de monócitos de ânion superóxido e as citoquinas de IL-1<225> e TNF<244>.
BR0016523-9A 1999-12-20 2000-12-20 Atividade sonogênica de bactérias não patogênicas de ácido láctico BR0016523A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/466,768 US6444203B2 (en) 1999-12-20 1999-12-20 Administering bacteria to improve sleep
PCT/EP2000/013020 WO2001045722A1 (en) 1999-12-20 2000-12-20 Somnogenic activity of non-pathogenic lactic acid bacteria

Publications (1)

Publication Number Publication Date
BR0016523A true BR0016523A (pt) 2002-09-24

Family

ID=23853027

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016523-9A BR0016523A (pt) 1999-12-20 2000-12-20 Atividade sonogênica de bactérias não patogênicas de ácido láctico

Country Status (19)

Country Link
US (1) US6444203B2 (pt)
EP (1) EP1251860B1 (pt)
JP (1) JP4527922B2 (pt)
AT (1) ATE328601T1 (pt)
AU (1) AU3161801A (pt)
BR (1) BR0016523A (pt)
CA (1) CA2394802A1 (pt)
CZ (1) CZ20022483A3 (pt)
DE (1) DE60028613T2 (pt)
DK (1) DK1251860T3 (pt)
ES (1) ES2266023T3 (pt)
HU (1) HUP0300025A3 (pt)
MX (1) MXPA02006116A (pt)
PL (1) PL202465B1 (pt)
PT (1) PT1251860E (pt)
RU (1) RU2262943C2 (pt)
SK (1) SK10662002A3 (pt)
WO (1) WO2001045722A1 (pt)
ZA (1) ZA200204974B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2785809B1 (fr) * 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
JP4891069B2 (ja) * 2004-03-31 2012-03-07 カルピス株式会社 内因性メラトニン分泌リズムの位相調整又は振幅増強剤、及び概日リズム改善剤
US20150147298A1 (en) * 2006-07-24 2015-05-28 CortControl, Inc. Sleep enhancement with cortisol reduction medical food
EP2110028A1 (en) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
AU2014221272B2 (en) * 2008-11-03 2016-01-21 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
EP2438821B1 (en) * 2008-11-03 2020-01-15 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
FR2938552B1 (fr) 2008-11-19 2010-12-03 Gervais Danone Sa Souche hypocholesterolemiante de lactobacillus delbrueckii
JP5923238B2 (ja) * 2010-07-07 2016-05-24 アサヒグループホールディングス株式会社 迷走神経活性化剤
MX2015005165A (es) * 2012-10-25 2015-10-29 Gervais Danone Sa Cepas de streptococcus thermophilus para tratar infeccion por helicobacter pylori.
EP3124031B1 (en) * 2014-03-25 2020-12-30 Kabushiki Kaisha Yakult Honsha Sleep quality improver
JP6127169B2 (ja) * 2016-02-15 2017-05-10 三基商事株式会社 睡眠改善剤
JP7154473B2 (ja) 2017-05-31 2022-10-18 学校法人順天堂 疲労回復用および／または疲労蓄積予防用組成物
US20200323227A1 (en) * 2017-12-19 2020-10-15 Compagnie Gervais Danone Fermented dairy compositions and methods of preparing the same
CN111297915B (zh) * 2019-04-12 2021-11-23 首都医科大学附属北京友谊医院 治疗帕金森病快速眼动期睡眠行为障碍的益生菌组合物、制剂及用途
MX2022001641A (es) * 2019-08-09 2022-05-03 Gervais Danone Sa Composiciones fermentadas y procedimientos de preparacion de las mismas.
EP4009798A1 (en) * 2019-08-09 2022-06-15 Compagnie Gervais Danone Fermented plant-based probiotic compositions and processes of preparing the same
JP2021123562A (ja) * 2020-02-05 2021-08-30 雪印メグミルク株式会社 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料
JP6873291B1 (ja) 2020-02-05 2021-05-19 雪印メグミルク株式会社 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料
JP7593740B2 (ja) * 2020-03-02 2024-12-03 株式会社明治 睡眠の質改善用組成物、全体的健康感改善用組成物および活力向上用組成物
CN113854457A (zh) * 2021-09-18 2021-12-31 山东绿丰生态农业股份有限公司 一种助睡眠促消化樱桃酵素固体饮品及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110476A (en) * 1977-01-10 1978-08-29 Johnson/Rhodes Cultured Foods, Inc. Preparation of liquid and frozen yogurt products
CH654330A5 (en) 1980-01-31 1986-02-14 Sp Kt Bjuro Dezi Process for the preparation of a biological product for stimulating vitality of humans and animals
US4624853A (en) * 1983-02-07 1986-11-25 S. C. Johnson & Son, Inc. Instant yogurt food product
US4698330A (en) 1983-06-27 1987-10-06 President & Fellows Of Harvard College Somnogenic compositions and method of use
DE3624010A1 (de) 1986-07-16 1988-01-28 Sen Wilhelm Kanne Arznei- bzw. heilmittel zur behandlung des ganzheitlichen menschlichen organismus
US4837036A (en) * 1987-05-22 1989-06-06 The Pro-Mark Companies, Inc. Low fat thin-bodied yogurt product and method
RU2012347C1 (ru) * 1990-06-08 1994-05-15 Колосовский Эрнест Дмитриевич Средство для лечения бессоницы
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
CN1114217A (zh) 1994-06-23 1996-01-03 南京肉类联合加工厂 生物活性口服液
EP0689769B1 (fr) * 1994-06-29 1999-09-01 Societe Des Produits Nestle S.A. Produit alimentaire fermenté pour animaux
AUPM864894A0 (en) 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
ES2126962T3 (es) * 1995-01-02 1999-04-01 Gervais Danone Co Fermento lactico, y su uso para la preparacion de productos antidiarreicos.
FR2771600B1 (fr) * 1997-11-28 2000-06-09 Gervais Danone Co Preparation de produits alimentaires par fermentation d'un melange de jus de soja et d'hydrolysat cerealier par streptococcus thermophilus
FR2793257B1 (fr) * 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations

Also Published As

Publication number Publication date
DE60028613T2 (de) 2007-05-31
WO2001045722A9 (en) 2002-09-12
HUP0300025A3 (en) 2004-12-28
DE60028613D1 (de) 2006-07-20
DK1251860T3 (da) 2006-10-16
HUP0300025A2 (en) 2003-05-28
CZ20022483A3 (cs) 2004-08-18
PL356459A1 (en) 2004-06-28
JP2003517828A (ja) 2003-06-03
JP4527922B2 (ja) 2010-08-18
RU2002119413A (ru) 2004-02-27
RU2262943C2 (ru) 2005-10-27
ATE328601T1 (de) 2006-06-15
US20010051152A1 (en) 2001-12-13
EP1251860A1 (en) 2002-10-30
MXPA02006116A (es) 2004-08-23
WO2001045722A1 (en) 2001-06-28
ZA200204974B (en) 2005-10-31
PL202465B1 (pl) 2009-06-30
PT1251860E (pt) 2006-10-31
US6444203B2 (en) 2002-09-03
ES2266023T3 (es) 2007-03-01
SK10662002A3 (sk) 2005-06-02
AU3161801A (en) 2001-07-03
EP1251860B1 (en) 2006-06-07
CA2394802A1 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
AU2001254624A1 (en) Human coagulation factor vii variants
NO962791D0 (no) Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse
AU3368497A (en) Human dnase i hyperactive variants
UA89944C2 (ru) Продуцирование высокоманнозных белков в растительных культурах
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
ATE481490T1 (de) Strukturprotein von aav, seine herstellung und verwendung
AU5161800A (en) Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
WO2001030965A3 (en) Methods of in vivo gene transfer using a sleeping beauty transposon system
HUP0004728A1 (hu) Javított eljárás nukleinsav bevitelére többsejtes eukarióta szervezet sejtjeibe és kombinált alkalmazása
AU2003266214A1 (en) Human coagulation factor vii polypeptides
HUP0203409A2 (hu) Gamma-interferon-konjugátumok
BR0010496A (pt) Regulação da expressão genica viral
MXPA02006116A (es) Actividad somnogenica de una bacteria acido lactica no-patogena.
TW200407425A (en) Human coagulation factor VII polypeptides
ATE331802T1 (de) Sequenz-spezifische dna-rekombination in eukaryotischen zellen
ES2187798T3 (es) Procedimiento de conservacion de virus recombinantes infecciosos, suspension acuosa viral y su utilizacion como medicamento.
WO2002008404A3 (en) Production of lysosomal enzymes in plants by transient expression
BR0114105A (pt) Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas
WO2002064757A3 (en) Influenza viruses with enhanced transcriptional and replicational capacities
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
WO2001074853A3 (en) Methods and products for regulating cell motility
EP0232523A3 (en) Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins
WO2000056866A3 (en) Akt-3 nucleic acids, polypeptides, and uses thereof
NO20006337L (no) Diarylselenidforbindelser og deres anvendelse i human- eller veterinærmedisin og i kosmetikk
WO2003092598A3 (en) Treatment for pompe disease

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: COMPAGNIE GERVAIS DANONE (FR)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020080108616/RJ DE 11/08/2008.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.